We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$706B
AUM Growth
-$5.71B
Cap. Flow
-$2.17B
Cap. Flow %
-0.31%
Top 10 Hldgs %
21.49%
Holding
2,592
New
52
Increased
1,566
Reduced
801
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 15.83%
3 Financials 13.92%
4 Consumer Discretionary 13.43%
5 Industrials 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACTG icon
2451
Acacia Research
ACTG
$455M
$97K ﹤0.01%
36,136
+268
+0.7% +$748
ERII icon
2452
Energy Recovery
ERII
$397M
$97K ﹤0.01%
10,470
+163
+2% +$1.64K
AXAS
2453
DELISTED
Abraxas Petroleum Corp
AXAS
$96K ﹤0.01%
9,452
-2,165
-19% -$30.6K
IMNN icon
2454
Imunon
IMNN
$6.77M
$93K ﹤0.01%
308
ASXC
2455
DELISTED
Asensus Surgical, Inc.
ASXC
$92K ﹤0.01%
11,476
+69
+0.6% +$938
HCR
2456
DELISTED
Hi-Crush Inc. Common Stock
HCR
$92K ﹤0.01%
52,974
-90,000
-63% -$173K
AVXL icon
2457
Anavex Life Sciences
AVXL
$316M
$90K ﹤0.01%
28,475
+196
+0.7% +$566
NE
2458
DELISTED
Noble Corporation
NE
$89K ﹤0.01%
69,788
+1,655
+2% +$2.83K
CLNE icon
2459
Clean Energy Fuels
CLNE
$384M
$87K ﹤0.01%
42,139
+680
+2% +$1.58K
BREW
2460
DELISTED
Craft Brew Alliance, Inc.
BREW
$87K ﹤0.01%
10,576
+63
+0.6% +$788
HBP
2461
DELISTED
Huttig Building Products, Inc.
HBP
$85K ﹤0.01%
40,446
SWBI icon
2462
Smith & Wesson
SWBI
$636M
$84K ﹤0.01%
18,773
+308
+2% +$1.86K
SRNE
2463
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$84K ﹤0.01%
39,325
+953
+2% +$2.22K
AKBA icon
2464
Akebia Therapeutics
AKBA
$248M
$83K ﹤0.01%
21,074
+651
+3% +$2.79K
RAIL icon
2465
FreightCar America
RAIL
$243M
$83K ﹤0.01%
17,100
VSTO
2466
DELISTED
Vista Outdoor Inc.
VSTO
$81K ﹤0.01%
13,049
-13,472
-51% -$88.8K
QUMU
2467
DELISTED
Qumu Corp.
QUMU
$79K ﹤0.01%
23,750
WVVI icon
2468
Willamette Valley Vineyards
WVVI
$11.5M
$75K ﹤0.01%
10,850
LTS
2469
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$74K ﹤0.01%
31,077
+537
+2% +$1.4K
NVTR
2470
DELISTED
Nuvectra Corporation Common Stock
NVTR
$73K ﹤0.01%
53,643
-37,700
-41% -$73.9K
LPTH icon
2471
Lightpath Technologies
LPTH
$862M
$72K ﹤0.01%
86,000
FTR
2472
DELISTED
Frontier Communications Corp.
FTR
$72K ﹤0.01%
83,281
+536
+0.6% +$603
FPRX
2473
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$70K ﹤0.01%
18,139
+136
+0.8% +$746
MOGU
2474
MOGU Inc
MOGU
$15.3M
$68K ﹤0.01%
+2,247
New +$71.8K
UEC icon
2475
Uranium Energy
UEC
$5.62B
$68K ﹤0.01%
69,691
+963
+1% +$976

Similar funds

T. Rowe Price Associates's Q3 2019 Portfolio in Review

As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
  • T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
  • T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
  • T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
  • T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
  • T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.

Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.